405 abstracts found.



Results filter

Molecular archaeology of cancer

Year:

Session type:

Peter Van Loo1,2

1The Francis Crick Institute, London, UK,2University of Leuven, Leuven, Belgium

Precision oncology

Year:

Session type:

Sandesh Kc1,Thomas King2,David Mak2,Rupesh Bhatt2,Alan Doherty2,Richard Viney2,Prashant Patel2,Brian Kelly2

1University Hospital Birmingham,2UHB

Molecular Imaging of Immunotherapies

Year:

Session type:

Sanjiv Gambhir1
1Stanford university

Applying genetic information to prevent colorectal cancer

Year:

Session type:

Malcolm Dunlop1
1University of Esinburgh

Co-existing Tumour-Immune Microenvironments in Advanced Ovarian Cancer

Year:

Session type:

Martin Miller1
1University of Cambridge

Adipocytes in the melanoma microenvironment

Year:

Session type:

Richard White1
1Memorial Sloan-Kettering Cancer Center

Precision medicine for melanoma: are we there yet?

Year:

Session type:

Richard Marais1
1CR-UK Manchester Institute

Options and Opportunities for Health Data Science

Year:

Session type:

Andrew Morris1
1Health Data Research UK

Mining genomic data to inform cancer prevention &  treatment strategies

Year:

Session type:

Richard Martin1
1University of Bristol

Multimorbidity in primary care: implications for cancer prevention, diagnosis and support

Year:

Session type:

David Blane1
1University of Glasgow

Understanding the role of multimorbidity on symptomatic presentation and early diagnosis of cancer

Year:

Session type:

Katriina Whitaker1
1University of Surrey

NHS Cancer Strategy

Year:

Session type:

David Fitzgerald1
1NHS England

Pre-clinical models of glioblastoma that enable more accurate evaluation of new treatment combinations

Year:

Session type:

Anthony Chalmers1
1Glasgow Centre for Cancer Research

Why is cancer so difficult?

Year:

Session type:

Martin Christlieb1
1University of Oxford

De-mystifying today’s science

Year:

Session type:

Elaine Vickers1
1Science Communicated

Why is behaviour change so difficult?

Year:

Session type:

Theresa Marteau1
1University of Cambridge

GvHD: uncoupling immunopathology from the graft-vs-leukemia effect.

Year:

Session type:

Burkhard Becher1
1University of Zurich

A personalised approach to treating patients with haematological malignancies

Year:

Session type:

Susanne Saussele1
1Universitätsmedizin Mannheim

Clone Wars in Leukaemia: Are there lessons for all cancers?

Year:

Session type:

Paresh Vyas1
1University of Oxford

Tumor-educated platelets for the detection and monitoring of cancer

Year:

Session type:

Thomas Wurdinger1
1VU University Medical Center

Use and safety of novel alternative nicotine delivery devices: a role for cancer harm reduction?

Year:

Session type:

Lion Shahab1
1University College London

Air pollution and cancer

Year:

Session type:

John Cherrie1
1Heriot Watt University and the Institute of Occupational Medicine

Carbon Nanotubes may pose Asbestos-style Cancer Risk

Year:

Session type:

Marion MacFarlane1
1MRC Toxicology Unit, University of Cambridge

Identifying the early cancerous body

Year:

Session type:

Rikke Sand Anderson1
1Aarhus University

Exploring genomic medicine at the interface of cancer research and clinical care

Year:

Session type:

Anne Kerr1
1University of Leeds

People Like You: Genomics in a London breast cancer service

Year:

Session type:

Sophie Day1
1Goldsmiths University, London

Myeloid cells in the ovarian cancer microenvironment

Year:

Session type:

Fran Balkwill1
1Barts Cancer Institute

Macrophages: Bad Actors in Cancer

Year:

Session type:

Jeffrey Pollard1
1The University of Edinburgh

Early pancreatic cancer diagnostics

Year:

Session type:

Stephen Pereira1
1University College London

Identifying and interpreting robust genetic dependencies in cancer cell lines

Year:

Session type:

Colm Ryan1
1University College Dublin

Applying genomics to tailor colorectal cancer screening in primary care

Year:

Session type:

Jon Emery1
1Centre for Cancer Research and Department of General Practice, University of Melbourne

New approaches in the diagnosis of lung cancer – from bench to primary care

Year:

Session type:

Richard Neal1
1University of Leeds

Intra-operative Electron beam radiotherapy for advanced and recurrent abdominopelvic malignancies in the UK: Development, implementation, and medium term results

Year:

Session type:

Alex Mirnezami1
1University of Southampton

Surgery-dependent Translational Research

Year:

Session type:

Richard Shaw1
1NIHR Cancer Research Network (NCRN)

Lung Cancer IO – hi ho

Year:

Session type:

Mary O'Brien1
1Royal Marsden NHS Hospital

Challenges in Managing the Immune Related Toxicities of Cancer Immunotherapy

Year:

Session type:

Paul Nathan1
1Mount Vernon Hospital

Surviving the Cure: Blood and Marrow Transplantation as Model For Cancer Survivorship

Year:

Session type:

Navneet Majhail1
1Cleveland Clinic

Identification of novel therapeutic targets for triple negative breast cancer through integrative kinomics

Year:

Session type:

Roger Daly1
1Department of Biochemistry and Molecular Biology, Monash University

Pancreatic Cancer Immunotherapy: From Bench to Bedside

Year:

Session type:

George Miller1
1New York University School of Medicine

Heterocellular interactions in the tumour microenvironment

Year:

Session type:

Claus Jorgensen1
1CRUK Manchester Institute

Chromosome breakage and inheritable cancers

Year:

Session type:

Stephen West1
1The Francis Crick Institute

Cell function and tumor formation

Year:

Session type:

Stefano Piccolo1
1University of Padua

Inflammation driven cancer: Genes, cells and microbes

Year:

Session type:

Fiona Powrie1
1Kennedy Institute of Rheumatology, University of Oxford

Evolutionary dynamics of cancer subclones

Year:

Session type:

Trevor Graham1
1Barts Cancer Institute

Targeting the DNA Damage Response with a Selective CHK1 Inhibitor

Year:

Session type:

Ian Collins1
1The Institute of Cancer Research

Discovery of first-in class, selective and noncovalent small molecule inhibitors of DNMT1

Year:

Session type:

Allan Jordan1
1CRUK Manchester Institute

Effect of a low-intensity PSA-based screening intervention on prostate cancer mortality: the CAP randomized clinical trial

Year:

Session type:

Richard Martin1
1University of Bristol

Methodological issues in precision oncology trials

Year:

Session type:

Lucinda Billingham1
1Cancer Research UK Clinical Trials Unit, University of Birmingham

Computational Pathology: Challenges and Opportunities

Year:

Session type:

Nasir Rajpoot1
1University of Warwick

Digital Pathology & Artificial Intelligence, the Third Revolution in Pathology

Year:

Session type:

Manuel Salto-Tellez1
1Queen's University Belfast